San Francisco, CA—Percutaneous closure of the patent ductus arteriosus (PDA) in children using a novel device is safe and effective, according to a prospective study presented in a featured clinical ...
The Food and Drug Administration clearance and CE mark position Abbott to sell its Amplatzer Piccolo Delivery System in the U ...
Abbott announced that the FDA approved a closure device for the treatment of premature babies with patent ductus arteriosus who are nonresponsive to medical management. The Amplatzer Piccolo occluder ...
First and only delivery system designed specifically for premature infants with a patent ductus arteriosus (PDA), a life-threatening opening in their heart New delivery system ...
Please provide your email address to receive an email when new articles are posted on . Compared with surgical ligation, transcatheter closure of the patent ductus arteriosus in infants and neonates ...
Nicklaus Children's Heart Institute Launches Bedside Transcatheter PDA Closure Offering for Newborns
New innovative capability brings lifesaving cardiac care directly to the NICU, reducing risks associated with transporting fragile premature infants. MIAMI , Sept. 22, 2025 /PRNewswire/ -- Nicklaus ...
In 2019, the U.S. Food and Drug Administration approved the first PDA occlusion device for infants as small as 700 grams, leading to rapid adoption of tcPDA in premature infants. Catheter-based ...
“This position statement represents a collective effort between neonatology, anesthesia, and interventional cardiology to provide comprehensive guidance on tcPDA device occlusion that can be adapted ...
Abbott (NYSE: ABT) received FDA clearance for its Amplatzer Piccolo delivery system for use with the Amplatzer Piccolo ...
Extremely low birth weight (ELBW) infants with moderate to large patent ductus arteriosus (PDA) may benefit from transcatheter PDA closure (TCPC) in the first four weeks of life, according to research ...
Nicklaus Children's Heart Institute Launches Bedside Transcatheter PDA Closure Offering for Newborns
The minimally invasive procedure involves placing a small catheter through a vein to deliver a tiny device that seals the PDA from within. The newly appointed chief of cardiovascular medicine and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback